Last update 23 Jan 2025

GDF x activin receptor

Basic Info

Related Targets
GDFactivin receptor

Related

1
Drugs associated with GDF x activin receptor
HS235
Target
GDF x activin receptor
Mechanism
GDF modulators [+1]
Active Org.
35Pharma, Inc.35Pharma, Inc.
Originator Org.
35Pharma, Inc.35Pharma, Inc.
Active Indication
Obesity
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with GDF x activin receptor
NCT06714825
/ RecruitingPhase 1
Phase 1 Single and Multiple Ascending Dose Study in Males and Females Assessing the Pharmacokinetics, Safety, and Pharmacodynamics of HS235 in Overweight and Obese Otherwise Healthy Subjects
100 Clinical Results associated with GDF x activin receptor
Login to view more data
100 Translational Medicine associated with GDF x activin receptor
Login to view more data
0 Patents (Medical) associated with GDF x activin receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free